Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low
UK law firms are considering legal action on behalf of women who developed brain tumours after using the contraceptive injection Depo-Provera.
Depo-Provera is a high-dose synthetic progesterone, prescribed for contraception and other menstrual symptoms, administered via injection every three months. According to UN calculations, 74 million women worldwide and 3.1% of UK women aged 15-49 use injectable contraception.
Continue reading...